Brian Mls Baker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brian Mls Baker has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Amy Six-Means
Amy Six-Means, MLIS, Medical Librarian, Library and School Services, Children's Health, Dallas, TX
1 shared publication Aqsa Sabir
Pediatric Hospital Medicine Program, Bakersfield Memorial Hospital, Bakersfield
1 shared publication- Arkadiusz Sitek
Radiology Department, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA
1 shared publication Benedikt Graf
IBM Watson Health (United States)
1 shared publication- Bindu Kanathezhath Sathi
Department of Pediatric Hematology/Oncology Valley Children's Health- care Madera CA USA
1 shared publication - Christine Lamoureux
Virtual Radiologic, Eden Prairie, USA
1 shared publication
Latest Publications
- 2 October 2023
- Published by Taylor & Francis in Medical Reference Services Quarterly
- Vol. 42 (4) , 352-369
Assessment of Library Services in Pediatric Hospitals in the United States and Canada
This study reports on a 2022 survey of pediatric hospital librarians in the U.S. and Canada to assess the status of staffing, resources, and services in their libraries. The report compares the data against the MLA Hospital Library Caucus Standards (2022) and the Canadian Hospital Library Association Standards (2020). The report also provides a comparison of the libraries' rankings using the Regional U.S. News & World Report Best Children's Hospitals and Magnet status. This approach is intended to determine how librarians and library services at hospitals that are recognized by the above programs differ from those that are not recognized.
- 2 October 2023
- Published by Taylor & Francis in Medical Reference Services Quarterly
- Vol. 42 (4) , 352-369
Assessment of Library Services in Pediatric Hospitals in the United States and Canada
This study reports on a 2022 survey of pediatric hospital librarians in the U.S. and Canada to assess the status of staffing, resources, and services in their libraries. The report compares the data against the MLA Hospital Library Caucus Standards (2022) and the Canadian Hospital Library Association Standards (2020). The report also provides a comparison of the libraries' rankings using the Regional U.S. News & World Report Best Children's Hospitals and Magnet status. This approach is intended to determine how librarians and library services at hospitals that are recognized by the above programs differ from those that are not recognized.
- 26 September 2022
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (2) , 82-87
SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature
Hemoglobin D-Los Angeles is a variant of hemoglobin that can polymerize in the deoxygenated state. When co-inherited with Hemoglobin S (HbSD-Los Angeles disease) a severe sickling syndrome similar to HbSS can result. Corona virus infectious disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome-corona virus-2. It has been associated with acute chest syndrome (ACS) in individuals with sickle cell disease (SCD), but this complication has not previously been reported in patients with HbSD-Los Angeles. Dexamethasone has been shown to improve outcomes in non-SCD patients with severe acute respiratory syndrome-corona virus-2 pneumonia or acute respiratory distress syndrome; however, its use in SCD patients with ACS is controversial due to a reported increased risk of complications including vaso-occlusive painful episodes. Herein, we reported a patient with HbSD-Los Angeles and COVID-19-associated ACS whom we treated with dexamethasone without transfusion. The patient experienced a rapid recovery without sequelae from steroid use. To further evaluate the use of steroids, we conducted a literature review focusing on the management of pediatric SCD patients with COVID-19-associated ACS. We identified a total of 39 pediatric patients with SCD and COVID-19, of whom 21 (54%) had ACS. Packed red blood cell transfusion (n=11), exchange transfusion (n=4), or a combination of exchange transfusion and packed red blood cell transfusion (n=4) were the most frequently reported treatment, with hydroxychloroquine (n=5), remdesivir (n=1), and tocilizumab (n=1) also being reported. Three patients were treated with dexamethasone. All patients recovered and no adverse outcomes from steroid use were reported. Even though transfusion is considered the standard of care for children with ACS and steroids are not routinely recommended, our experience suggested that COVID-19-associated ACS may be an important exception, especially for patients who refuse transfusion or are in resource-poor nations where blood transfusions may not be readily available. Further studies are warranted to confirm these observations.
- 26 September 2022
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (2) , 82-87
SARS-CoV-2 Infection Presenting as Acute Chest Syndrome in a Child With Hemoglobin SD-Los Angeles Disease: A Case Report and Review of Literature
Hemoglobin D-Los Angeles is a variant of hemoglobin that can polymerize in the deoxygenated state. When co-inherited with Hemoglobin S (HbSD-Los Angeles disease) a severe sickling syndrome similar to HbSS can result. Corona virus infectious disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome-corona virus-2. It has been associated with acute chest syndrome (ACS) in individuals with sickle cell disease (SCD), but this complication has not previously been reported in patients with HbSD-Los Angeles. Dexamethasone has been shown to improve outcomes in non-SCD patients with severe acute respiratory syndrome-corona virus-2 pneumonia or acute respiratory distress syndrome; however, its use in SCD patients with ACS is controversial due to a reported increased risk of complications including vaso-occlusive painful episodes. Herein, we reported a patient with HbSD-Los Angeles and COVID-19-associated ACS whom we treated with dexamethasone without transfusion. The patient experienced a rapid recovery without sequelae from steroid use. To further evaluate the use of steroids, we conducted a literature review focusing on the management of pediatric SCD patients with COVID-19-associated ACS. We identified a total of 39 pediatric patients with SCD and COVID-19, of whom 21 (54%) had ACS. Packed red blood cell transfusion (n=11), exchange transfusion (n=4), or a combination of exchange transfusion and packed red blood cell transfusion (n=4) were the most frequently reported treatment, with hydroxychloroquine (n=5), remdesivir (n=1), and tocilizumab (n=1) also being reported. Three patients were treated with dexamethasone. All patients recovered and no adverse outcomes from steroid use were reported. Even though transfusion is considered the standard of care for children with ACS and steroids are not routinely recommended, our experience suggested that COVID-19-associated ACS may be an important exception, especially for patients who refuse transfusion or are in resource-poor nations where blood transfusions may not be readily available. Further studies are warranted to confirm these observations.
- Open Access
- 4 April 2022
- Published by SPIE-Intl Soc Optical Eng
- p. 135
Multi-institutional evaluation of a deep learning model for fully automated detection of aortic aneurysms in contrast and non-contrast CT
SPIE Digital Library Proceedings
- 4 April 2022
- Published by SPIE-Intl Soc Optical Eng
- p. 135
Open AccessMulti-institutional evaluation of a deep learning model for fully automated detection of aortic aneurysms in contrast and non-contrast CT
SPIE Digital Library Proceedings
- 14 June 2017
- Published by Taylor & Francis in Journal of Hospital Librarianship
- Vol. 17 (3) , 230-238
Taking the Luxury out of Literacy: The Valley Children’s Hospital Literacy Program Story
(2017). Taking the Luxury out of Literacy: The Valley Children’s Hospital Literacy Program Story. Journal of Hospital Librarianship: Vol. 17, No. 3, pp. 230-238.
- 14 June 2017
- Published by Taylor & Francis in Journal of Hospital Librarianship
- Vol. 17 (3) , 230-238
Taking the Luxury out of Literacy: The Valley Children’s Hospital Literacy Program Story
(2017). Taking the Luxury out of Literacy: The Valley Children’s Hospital Literacy Program Story. Journal of Hospital Librarianship: Vol. 17, No. 3, pp. 230-238.